Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebivolol for Microvascular Angina in Women
NCT01665508Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nebivolol in microvascular angina (MVA), sponsored by Massachusetts General Hospital. Primary endpoint: Seattle Angina Questionnaire Score at 3 months. Started Apr 2013; status: completed.
02
Drugs
nebivolol
03
Conditions
microvascular angina (MVA)
Beyond the preview
Go deeper on NCT01665508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01665508.